Remove 2019 Remove FDA Remove Side effects
article thumbnail

Biogen is in deep trouble and may not survive

World of DTC Marketing

Biogen undertook a secret campaign, termed Project Onyx, to persuade FDA to approve Aduhelm. As soon as the FDA gave Aduhelm approval, investors rushed to buy Biogen’s stock, and the executive was spreading Kool-aid about the product’s efficacy. Biogen’s reputation may be damaged beyond repair.

article thumbnail

Is DTC effective?

World of DTC Marketing

During the first quarter of 2020, the number of telehealth visits increased by 50%, compared with the same period in 2019, with a 154% increase in visits noted in surveillance week 13 in 2020, compared with the same period in 2019. What are the side effects? That belief is out the window.

article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. Washington Post.

FDA 187
article thumbnail

Elon Musk’s Neuralink brain interface chip set for human trials

pharmaphorum

Neuralink has been promising that the technology will be ready for clinical trials soon for some time – first saying they were around the corner back in 2019 – so the latest announcement by Musk at an update last week may be met with some scepticism. Take action! Retweet this thread and tell @elonmusk to release the tapes! link] (12/12).

article thumbnail

Can a nasal spray tackle agitation in autism?

Pharmaceutical Technology

Janssen’s Risperdal (risperidone), a second-generation antipsychotic , got its first FDA approval for autism-related irritability for children over the age of five, in 2006. Generic versions of both drugs are now available. The route of administration is another hurdle as both drugs come in the forms of oral pills or injections.

article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen. Regarding both common cold and headache, they are as well among the side effects reported for similar drugs.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

we must prove the effectiveness of radiopharmaceuticals through clinical trials… This has been demonstrated recently with PLUVICTO… the first US Food and Drug Administration (FDA)-approved targeted radioligand therapy for eligible patients with prostate cancer” At this moment, there is no single treatment for cancer today.